Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5 [Phase 4]
Phase 4 trial update on converting from standard phosphate binder therapy to Fosrenol (lanthanum carbonate) in chronic kidney disease stage …
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test [Phase 2]
Phase II trial evaluating IdeS to desensitize transplant patients with a positive crossmatch; study completed with results posted.
-
FDA approval · 2021-05-17FDA Approved: SEVELAMER CARBONATE — Original Application (Bionpharma Inc.)
FDA approved the original application for sevelamer carbonate from Bionpharma Inc., a generic phosphate binder for managing hyperphosphatemi…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Multi-center Study to Transplant Hepatitis-C Infected Kidneys [Phase 4]
A multi-center Phase 4 trial evaluated transplanting kidneys from hepatitis C-infected donors into recipients with renal failure, with resul…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]
Phase 3 trial evaluating MT-6548 in hemodialysis patients with CKD-related anemia completed; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) [Phase 3]
Phase 3 head-to-head trial comparing etelcalcetide with cinacalcet in Asian hemodialysis patients with secondary hyperparathyroidism has com…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Physical Activity in Renal Disease (PAIRED): The Effect on Hypertension [Phase 3]
Phase 3 trial update for the PAIRED study evaluating physical activity effects on hypertension in chronic kidney disease; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Sodium Intake in Chronic Kidney Disease (STICK) [Phase 2]
Phase 2 clinical trial update on sodium intake in chronic kidney disease assessing effects on kidney-related outcomes.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD [Phase 4]
Phase 4 trial evaluating safety and cardiovascular efficacy of hydralazine combined with isosorbide dinitrate in patients with dialysis-depe…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease [Phase 3]
A Phase 3 trial evaluating TRC101 for metabolic acidosis in chronic kidney disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) [Phase 2]
Phase 2 trial update for Autologous Neo-Kidney Augment (NKA) in patients with Type 2 Diabetes and Chronic Kidney Disease; study terminated w…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial [Phase 2]
Phase 2 trial update for the NICE trial investigating nitrite and isoquercetin in endothelial dysfunction among patients with chronic kidney…
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease [NA]
Clinical trial update on a sick-day protocol intended to improve outcomes in chronic kidney disease is completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]
Phase 3 efficacy and safety study MT-6548 in non-dialysis chronic kidney disease patients with anemia has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]
Phase 3 efficacy and safety study evaluating MT-6548 in adults with anemia associated with chronic kidney disease requiring hemodialysis in …
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Comparing Sevoflurane With Propofol Sedation in ESRF Patients [Phase 4]
Phase 4 trial updating results on sevoflurane versus propofol sedation in patients with kidney disease undergoing procedures.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD [Phase 4]
A Phase 4 trial update comparing dabigatran to warfarin in atrial fibrillation patients with type 2 diabetes and chronic kidney disease. The…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) [Phase 4]
A Phase 4 clinical trial update for KRX-0502 (ferric citrate) in patients with non-dialysis dependent chronic kidney disease and iron defici…
-
FDA approval · 2021-03-10FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Ferric Citrate from Mylan Pharmaceuticals, approving a supplemental NDA for the product (NDA…
-
FDA approval · 2021-03-02FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for ZEMPLAR (paricalcitol) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia [Phase 4]
A Phase 4 trial comparing lanthanum versus calcium carbonate for vascular abnormalities in patients with chronic kidney disease and hyperpho…
-
CLINICAL_TRIALS research · 2021-02-16Clinical Trial Update: Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients [Phase 4]
A Phase 4 trial evaluating whether Vitamin D3 supplementation affects arterial and bone remodeling in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC [NA]
A completed clinical trial comparing VectorFlow Tunneled Dialysis Catheter (TDC) with Palindrome TDC in patients requiring hemodialysis for …
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis [Phase 4]
Open-label Phase 4 pharmacokinetic study of gabapentin in Japanese subjects with renal impairment including hemodialysis was terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects [Phase 3]
Phase 3 trial update of molidustat for renal anemia in peritoneal dialysis patients has completed.